ABSTRACT
Neuroendocrine tumors consist of a spectrum of malignancies that arise from the diffuse neuroendocrine cell system. Prognosis is dependent on histologic subtype and site of origin. The family of well-differentiated neoplasms (carcinoid and atypical carcinoid) is morphologically and clinically distinct from high-grade neuroendocrine carcinoma (small cell and large cell). This latter entity is closely related to pulmonary small-cell carcinoma, is highly aggressive and is generally managed with a multimodality approach including platinum-based chemotherapy. Neuroendocrine tumors primary to the gynecologic tract are still considered to be uncommon, with limited prospective data available to guide decision making. We are reporting a case of a highly aggressive small-cell neuroendocrine carcinoma cervix in a 38-year-old female with good initial response with chemotherapy and is under our follow-up.